Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published inย JAMA Dermatology.

โ€œIn recent months, state and federal policies have been enacted to ban gag clauses on pharmacists and in commercial insurance contracts,โ€ย Joslyn Kirby, MD, MS, MEd,ย of the department of dermatology, Penn State Milton S. Hershey Medical Center, and colleagues wrote. โ€œGag clauses prevented pharmacists from proactively informing patients if it is more cost-effective to purchase their prescription out of pocket.โ€